Melinta Therapeutics stock slides after company files for chapter 11 bankruptcy protection

Shares of biotech Melinta Therapeutics Inc. slid 59% Friday, after the developer of novel antibiotics to treat bacterial infections filed for chapter 11…

Read the full article here

Related Articles